The Inflation Reduction Act was intended to lower prescription drug costs, but an unintended consequence is threatening the ...

NBE Therapeutics (NBE) a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel. This milestone reinforces its commitment to innovation in oncology and ...

Vinay Rajani of HDFC Securities recommends these three stocks in the near term - HealthCare Global Enterprises Ltd, Aadhar ...

Medicamen Biotech stock rose following the announcement of a strategic partnership with XGX Pharma, a European company.

After closing at Rs 67, the stock price of Balaxi Pharmaceuticals Ltd. climbed by 10% to hit the upper circuit limit of Rs 73 ...

Indian companies supply around 40% of all generic drugs used in the US; Pharmaceuticals remain untouched by US’ tariff ...

Over the last two months, the pharmaceutical industry has remained on the sidelines as Health and Human Services Secretary Robert F. Kennedy Jr. and Elon Musk’s Department of Government Efficiency ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an initial public offering (IPO) on the week of April 7th, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on the week of April 7th, IPO Scoop reports.

Lonza Group AG / Key word (s): Annual Results/Sustainability Lonza Publishes Invitation to the 2025 Annual General Meeting and 2024 Annual and Sustainability Reports 03-Apr-2025 / 07:00 CET/CEST ...

As U.S. President Donald Trump takes aim at the mostly American-owned pharmaceutical factories that dot the Irish countryside ...

Juan Carlos Scott, president and CEO of the Pharmaceutical Care Management Association (PCMA), and Marissa Schlaifer, RPh, ...